|
Report Date : |
07.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
SUZHOU LEADER IMP & EXP CO., LTD |
|
|
|
|
Registered Office : |
Room 2010, Building 1, No.88, Shishan Rd, Gaoxin Dist, Suzhou, Zip Code 215011 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
03.04.2009 |
|
|
|
|
Com. Reg. No.: |
320512000095234 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Wholesaler of pharmaceutical intermediates |
|
|
|
|
No. of Employees : |
20 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUZHOU
LEADER IMP & EXP CO., LTD
Currency in this report is Chinese Yuan unless otherwise stated.
Exchange Rate: 1 USD=6.34 Chinese Yuan
"--"in this report indicates "unavailable" due to
insufficient information or "no comments"
|
name |
Suzhou Leader Imp & Exp Co Ltd. |
|
address |
Room 2010 Gold
River Center No. 88 Shishan Road Suzhou 215011 P.R. |
|
DATE OF establishment |
Apr.3rd, 2009 |
|
Aic Registration No. |
320512000095234 |
|
REGISTERED LEGAL FORM |
limited liabilities
company |
|
REGISTERED CAPITAL |
1,000,000.00 |
|
main BUSINESS |
Wholesale
of pharmaceutical intermediates |
|
tax no. |
320512687804231 |
|
employees |
20 |
|
import and export permits |
yes |
|
EXCHANGE RATE |
1 Usd=6.34CNY (Jun.1st, 2012) |
|
Registered Address |
Room 2010, Building 1, No.88, Shishan Rd, Gaoxin Dist, Suzhou |
|
Zip Code |
215011 |
|
|
|
|
Business Address |
Room 2010, Gold River Center, No. 88, Shishan Rd, Suzhou |
|
Zip Code |
215011 |
|
Telephone |
86 512 68187655 |
|
Fax |
86 512 68187355 |
|
|
|
|
SIC Code (China) |
6351 wholesale of western medicine |
|
Name (Chinese) |
苏州瑞达恩进出口有限公司 |
|
Name (English) |
SUZHOU LEADER IMP & EXP CO., LTD |
|
Date of Establishment |
Ar. 3rd, 2009 |
|
Registry |
Administration Bureau for Industry and
Commerce - Huqiu, Suzhou |
|
Legal Representative |
Zeng Deli |
|
AIC Registration Number |
320512000095234 |
|
Registered Legal Form |
Limited liabilities
company |
|
Registered Capital |
1,000,000.00 |
|
Operating Duration |
Apr. 3rd, 2009 to Apr. 2nd,
2029 |
|
Business Scope |
Sales of ordinary
machinery, electronics, chemicals, agricultural products, art crafts,
textile, silk products, stationery, hardware, garments, building materials,
auto parts, computer and peripherals, wooden products etc; Import and export of
commodities and technologies |
Limited
liabilities co.
This
form of business in PR China is defined as a legal person. Its registered
capital is contributed jointly by at least two shareholders and no more than
fifty. Shareholders bear limited liability to the extent of shareholding, and
the co. is liable for its debts only to extent of its total assets. The
characteristics of this form of co. are as follows:
Upon
the establishment of the co., an investment certificate is issued to the each
of shareholders.
The
board of directors is comprised of three to thirteen members.
The minimum registered capital for a
co. is listed as follows:
-manufacturing
co. : RMB 500,000.00
-trading
&wholesaling co. : RMB 500,000.00
-retailing
co. : RMB 300,000.00
-consultancy
& service co. : RMB 100,000.00
Shareholders
may take their capital contributions in cash or by means of tangible assets or
intangible assets such as industrial property and non-patented technology.
Cash
contributed by all shareholders must account for at least 50% of the registered
capital while contribution by intangible assets must not exceed 20% of the
registered capital.
Existing
shareholders have pre-exemption right to purchase shares of the co. offered for
sale by the other shareholders and to subscribe for the newly increased
registered capital of the co.
REGISTRATION
INFO: AVAILABLE
FINANCIAL
REPORTS: AVAILABLE
Subject's income comes
mainly from sales of pharmaceutical intermediates. The products are exported to
international traders and pharmaceutical manufacturers. The pharmaceutical
wholesale industry is an industry with fierce competition. With short history,
subject's hasn't accumulated sufficient customer network. The overall
competitiveness is below average.
Located at the shore of
Taihu Lake and the nearby the estuary of Changjiang River, Suzhou city hold
convenient traffic condition with major railways and highways crossing the
city. It is not only the cultural and educational center of Jiangsu Province,
but also important economic, trading and logistic center. In 2011, the GDP of
Suzhou City ranked No.6 in china mainland.
As indicated in
the following table:
|
Shareholder |
Capital
Subscribed |
Percentage |
|
Gu Haiyan |
100,000.00 |
10% |
|
Shen Qing |
350,000.00 |
35% |
|
Sun Xiaopeng |
100,000.00 |
10% |
|
Zeng Deli |
450,000.00 |
45% |
|
Total |
1,000,000.00 |
100% |
|
Shareholder |
Way
of Investment |
Paid-up
Percentage |
|
Gu Haiyan |
Capital
|
100% |
|
Shen Qing |
Capital
|
100% |
|
Sun Xiaopeng |
Capital
|
100% |
|
Zeng Deli |
Capital |
100% |
|
Related Company Name |
Suzhou Leader Chemical Co., Ltd |
|
Address |
No.6
Jinshan Road, Suzhou City |
|
Main business |
Manufacture of BPC, pharmaceutical
intermediates and refined chemicals |
|
Name |
Zeng Deli |
|
Gender |
Male |
|
Title |
Executive director; general manager |
|
Date of birth |
Mar.6th, 1965 |
|
Working experience |
Industry experience:
more than 5 years; Management experience:
more than 5 years |
|
|
|
|
Name |
Shen Qing
|
|
Gender |
Male |
|
Title |
Supervisor |
|
Date of birth |
May 19th, 1964 |
Employees:
20
Management
Staff: 5
Recent
recruitment: No
|
Bank name |
Industrial and
Commercial Bank of China - Suzhou Branch |
|
Account No. (CNY) |
-- |
|
Tel. |
86 512 68268179 |
|
Comment |
the above information
is provided by subject's staff. However, the bank staff refused to disclose
any information. |
|
Geographic Location |
Room 2010, Gold River Center, No. 88, Shishan Rd, Suzhou City, Jiangsu
Province |
|
Area |
200 square meters |
|
Environment |
Office premise |
|
Traffic condition |
With neighborhood of Binhe Road, Jinshan
Road, Shishan Road etc. The traffic condition here is good. |
|
Purpose |
Office |
|
Property Ownership |
Rented |
|
Website |
|
|
e-mail |
|
|
Operation status |
Operational |
|
Copyright |
Subject |
|
Language |
English only |
After
checking with the Trademark Office of Chinese Administration Bureau of Industry
and Commerce and the State Intellectual Office, no trademarks or patents of SC
were found.
|
Main business |
Wholesale of AI
and pharmaceutical intermediates |
|
Products and services |
Intermediates,
veterinary drugs, anti-cancer APIs, anti-depressionAPIs etc. The products are
manufactured by subject's related company Suzhou Leader Chemical
Co., Ltd. |
|
Export |
100% |
|
Regions |
Europe,
America, Australia, Mid-east, Africa etc. |
|
Major overseas clients |
Traders; pharmaceutical manufacturers |
|
Competitors
|
QINGDAO HUANGHAI PHARMACY
CO.,LTD; SHANGHAI NEW HUALIAN
PHARMACEUTICAL CO., LTD; QILU PHARMACEUTICAL CO.,
LTD; GUANGZHOU BAIYUNSHAN
PHARMACEUTICAL CO.,LTD |
|
Payment terms |
L/C, T/T |
|
Subject's
products are all exported. |
|
|
The above information was
confirmed by SC’s employee |
|
|
Main Commodities Purchased |
pharmaceutical
intermediates, anti-cancer API etc. |
|
Number of Major Suppliers |
About 3 |
|
Region |
Domestic: 100% Import: 0% |
|
Major suppliers |
Suzhou Leader Chemical Co., Ltd; SHANGHAI MENGXUAN
EXHIBITION SERVICE CO. LTD |
|
Main Terms of Payment |
Local: Prompt payment; on
credit |
|
Subject's
products are supplied by its related company Suzhou Leader Chemical
Co., Ltd. |
|
|
The above information was confirmed by SC’s
employee |
|
|
Name of supplier |
Suzhou Leader Chemical
Co., Ltd |
|
Main commodities and service supplied |
pharmaceutical
intermediates |
|
Interviewee |
Ms Ding (office
staff) |
|
Telephone of Interviewee |
0512-68412652 |
|
Payment comment |
Prompt |
After checking with
China Court organization, the local court website and other major searching
websites, no litigation record related to SC in the latest three years is
found.
NO
1. Introduction of subject: http://www.eb80.com.cn/CompanyShow_849_3470326.Html
2. Subject's product
information: http://leadertrade.company.lookchem.cn/offerlist/
3. Subject participated
exhibition: http://www.zgycsc.com/luntan/read.php?tid=18602
4. Subject's information in
Alibaba website: http://china.alibaba.com/company/detail/leadertrade107.html; http://leaderchem.en.alibaba.com/aboutus.html
According to subject's staff Mr. Sun, subject's business scale is average in the industry. Its annual sales volume of 2011 was about 10-12 million CNY. And the sales volume of 2012 is estimated to be higher than 12 million CNY.
Industry Ratios:
|
|
2010 |
|
Return on net
assets (%) |
20.29 |
|
Return on total
assets (%) |
3.73 |
|
Net profit
margin (%) |
1.66 |
|
Turnover of
total assets |
2.27 |
|
Turnover of
current assets |
2.39 |
|
Turnover days of
account receivable |
60.93 |
|
Inventory
turnover days |
47.68 |
|
Asset liability
ratio (%) |
83.52 |
|
Current ratio |
1.17 |
|
Quick ratio |
0.91 |
Industry
SIC
Code (China): 6351 wholesale of
western medicines
Description: Wholesale, import and export of chemical
pharmaceutical raw material (antibiotics, vitamin, dextrose, alkaloid, etc),
chemical pharmaceutical preparation (troche, injection, liquid medicine,
ointment, etc), bio-pharmaceuticals (vaccine, bacteria, biological antibiotics,
etc) and other unlisted western medicine
Status Quo & Trend
The western
medicine industry plays an important role in pharmaceutical market. In 2010,
the import and export status of western medicine industry was improved a lot
from 2009. The total import and export volume reached 36.371 billion dollars,
increasing 25.45% year/year. The competition of western medicine industry will
become more and more furious as the new healthcare reform measures are
implemented.
Since 2011, the government has been paying increasing attention to
people's healthcare sector. Healthcare would become affordable for most
consumers. Meanwhile, competition in pharmaceutical industry would become more
fierce.
In 2012, the exposure of poisonous capsules impacted the development of
pharmaceutical industry. Enterprises have to spend more energy and capital to
retrieve trust of consumers in order to develop further.
Industry Associations
|
Name of association |
Membership of subject (Yes/No) |
|
China Pharmaceutical Technology Organization |
Not Known |
|
China Association of Pharmaceutical Commerce |
Not Known |
|
Shanghai biological medicine industry association |
Not Known |
|
Chinese Association of Minority Medicine |
Not Known |
Established in Apr. 2009,
subject is engaged in export of pharmaceutical intermediates which are supplied
by its related company. With short history and unstable staff, its industry
experience is limited. With individual shareholders, subject's financing and
risk resisting ability are both weak. In order to obtain further development,
it should expand the domestic market while stabilizing the international
market.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.50 |
|
UK Pound |
1 |
Rs.85.58 |
|
Euro |
1 |
Rs.69.30 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.